Reprogrammed Interchange LLC - 17 Oct 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Oct 2025, 17:45:04 UTC
Prior SEC filing
17 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Reid Hoffman

Key filing fact

Reprogrammed Interchange LLC filed Form 4 for Vor Biopharma Inc. (VOR) on 21 Oct 2025.

Key facts

  • This page summarizes Reprogrammed Interchange LLC's Form 4 filing for Vor Biopharma Inc. (VOR).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Oct 2025, 17:45.

Change

  • Previous filing in this sequence was filed on 17 Oct 2025.
  • Current net transaction value: -$1,133,103.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0002050755 Primary reporting owner

Reprogrammed Interchange LLC

Relationship
10%+ Owner
Address
101 MISSION STREET, SUITE 1000, SAN FRANCISCO
Signature
/s/ Reid Hoffman
Signature date
21 Oct 2025
CIK 0001519339

Hoffman Reid

Relationship
10%+ Owner
Address
101 MISSION STREET, SUITE 1000, SAN FRANCISCO
Signature
/s/ Frank Huang, Manager of Reprogrammed Interchange LLC
Signature date
21 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VOR transaction

Common Stock

Sale

Transaction value
$746,119
Shares
-24,689
Change %
-2%
Price
$30.22
Shares after
1,179,753
Date
17 Oct 2025
Ownership
Direct
Footnotes
F1, F2
VOR transaction

Common Stock

Sale

Transaction value
$31,868
Shares
-1,028
Change %
-0.09%
Price
$31.00
Shares after
1,178,725
Date
17 Oct 2025
Ownership
Direct
Footnotes
F2
VOR transaction

Common Stock

Sale

Transaction value
$349,101
Shares
-11,616
Change %
-0.99%
Price
$30.05
Shares after
1,167,109
Date
20 Oct 2025
Ownership
Direct
Footnotes
F2, F3
VOR transaction

Common Stock

Sale

Transaction value
$6,015
Shares
-200
Change %
-0.02%
Price
$30.08
Shares after
1,166,909
Date
21 Oct 2025
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Footnote F2

The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .